Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ROCKET PHARMACEUTICALS, INC. (RCKT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.00.00.0
            Revenue growth         -100.0%
Cost of goods sold  1.21.10.90.90.00.00.00.0
Gross profit  -1.2-1.1-0.9-0.90.00.00.00.0
            Gross margin          
Selling, general and administrative   [+]58.841.828.918.217.94.91.67.8
Research and development  165.6125.5105.457.953.314.96.012.6
Other operating expenses  -1.2-1.1-0.9-0.9    
EBITDA   [+]-220.4-164.0-133.2-75.7-70.8-19.6-7.5-20.4
            EBITDA margin          
Depreciation and amortization  3.93.21.10.40.30.20.10.0
EBIT   [+]-224.3-167.2-134.3-76.2-71.2-19.8-7.6-20.4
            EBIT margin          
Interest expense, net   [+]1.93.07.06.06.0  1.1
Other income (expense), net   [+]4.31.21.64.82.70.20.0-46.4
Pre-tax income  -221.9-169.1-139.7-77.3-74.5-19.6-7.6-68.0
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -221.9-169.1-139.7-77.3-74.5-19.6-7.6-68.0
            Net margin          
   
Basic EPS   [+]($3.26)($2.67)($2.52)($1.58)($1.89)($2.88)($1.11)($3.71)
Diluted EPS   [+]($3.26)($2.67)($2.52)($1.58)($1.89)($2.88)($1.11)($3.71)
   
Shares outstanding (basic)   [+]68.163.255.449.039.46.86.818.3
Shares outstanding (diluted)   [+]68.163.255.449.039.46.86.818.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy